Document is current

Any future updates will be listed below

Correction to: A Canadian real‑world, multi‑center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2‑negative advanced breast cancer

Crossref DOI link: https://doi.org/10.1007/s10549-026-07934-4

Published Online: 2026-03-19

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark